CD44 and central nervous system cancer: For seven studies, glioma tissue CD44 expression was measured by immunohistochemistry [28–32,34,35], while for the rest studies, quantitative reverse transcription polymerase chain reaction (qRT-PCR) was applied [25–27,33].